With the relatively rapid development of the COVID-19 pandemic, vaccine development has
become crucial for limiting disease transmission. The accelerated growth in the approved …

Background A correlate of protection (CoP) is an immunological marker associated with
protection against infection. Despite an urgent need, a CoP for SARS-CoV-2 is currently …

Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …

Vaccination has a significant impact on morbidity and mortality. High vaccination coverage
rates are required to achieve herd protection against vaccine-preventable diseases …

Background An estimated one fourth of the world's population is infected with
Mycobacterium tuberculosis, and 5–10% of those infected develop tuberculosis in their …

In response to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
pandemic, over 200 vaccine candidates against coronavirus disease 2019 (COVID-2019) …

In the 21st century, an array of microbiological and molecular allow antigens for new
vaccines to be specifically identified, designed, produced and delivered with the aim of …

Billions of doses of COVID-19 vaccines have been administered globally, dramatically
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …

Typhoid Vi vaccines have been shown to be efficacious in children living in endemic
regions; however, a widely accepted correlate of protection remains to be established. We …

Globally, group B Streptococcus (GBS) remains the leading cause of sepsis and meningitis
in young infants, with its greatest burden in the first 90 days of life. Intrapartum antibiotic …